3.8 Article

Practical recommendations of the German Diabetes Society for the management of diabetes in patients with COVID-19

Journal

DIABETOLOGE
Volume 17, Issue 1, Pages 36-41

Publisher

SPRINGER HEIDELBERG
DOI: 10.1007/s11428-020-00715-7

Keywords

Diabetes therapy; COVID 19 disease; SARS CoV 2 infection; Type 1 diabetes; Type 2 diabetes

Ask authors/readers for more resources

Diabetes and cardiovascular diseases are common comorbidities in COVID-19 patients, with diabetes patients having a higher risk for severe disease progression. The exact relationship between diabetes and the clinical course of COVID-19 is not completely understood at present. The German Diabetes Association provides basic practice recommendations for treating patients with both diabetes and COVID-19.
In subjects with an infection with the novel corona virus SARS-CoV-2 and COVID-19 disease, diabetes mellitus and cardiovascular diseases are highly prevalent comorbidities. Diabetes patients with comorbidities and/or diabetes complications seem to have a higher risk for a severe course of the COVID-19 disease including the development of ARDS or multiorgan failure. The exact interrelations between diabetes and the individual clinical course of COVID-19 are not completely understood at this time. The German Diabetes Association (DDG) summarizes basic principle practice recommendations for the treatment of patients with diabetes and concomitant COVID-19 disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available